Licogliflozin, a Novel SGLT1 and 2 Inhibitor: Body Weight Effects in a Randomized Trial in Adults With Overweight or Obesity
Obesity - United States
doi 10.1002/oby.22764
Full Text
Open PDFAbstract
Available in full text
Date
March 18, 2020
Authors
Publisher
Wiley